STOCK TITAN
  1. Home
  2. Sec-filings
  3. CVKD
  4. [144] Cadrenal Therapeutics, Inc. SEC Filing

CVKD (NASDAQ: CVKD) Form 144 lists Quang X. Pham sales of common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CVKD reported multiple resale transactions of Common Stock by Quang X. Pham under Form 144. The filing lists individual dispositions on several dates in May–June 2026, including sales of 12,996 shares on 06/12/2026 and 12,992 shares on 06/09/2026.

The record also shows a line identifying Founders Shares: 40,000 shares (01/25/2022). The filing lists each sale with the number of shares and gross proceeds per trade; cash‑flow treatment is the selling holder's proceeds.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists numerous individual dispositions by a single holder, presented as resale transactions.

Form 144 entries name Quang X. Pham and list dated sales with share counts and gross proceeds. The filing format shows routine resale reporting rather than an issuer offering.

Timing and aggregate totals are shown by per‑trade rows in the excerpt; subsequent filings may disclose additional context such as broker or plan details.

Founders Shares 40,000 shares 01/25/2022
Largest single reported sale (excerpt) 12,996 shares 06/12/2026
Other large sale shown 12,992 shares 06/09/2026
Example gross proceeds for a trade $51,180.32 proceeds for 12,996 shares on 06/12/2026
Form 144 regulatory
"lists dated resale transactions by a selling security holder"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares financial
"Founders Shares | Issuer | 40000 | 01/25/2022"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Gross proceeds financial
"each sale row includes a dollar amount listed after the share count"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does the CVKD Form 144 disclose about sales by Quang X. Pham?
It discloses multiple dated dispositions of Common Stock by Quang X. Pham, listing share counts and gross proceeds for each trade across May–June 2026. The filing presents per‑trade details such as 12,996 shares on 06/12/2026.

How many shares are identified as Founders Shares in the excerpt for CVKD?
The excerpt includes a line identifying Founders Shares: 40,000 shares with an issuance date of 01/25/2022. The filing shows that figure as a labeled security entry within the provided content.

Does the Form 144 show aggregate proceeds for the reported sales?
The excerpt lists gross proceeds per trade alongside each sale (e.g., $51,180.32 for 12,996 shares on 06/12/2026). It does not present an explicit aggregate proceeds total in the provided lines.

Are these sales reported as issuer offerings or selling‑holder transactions?
The entries are selling‑holder transactions attributed to Quang X. Pham. The filing rows list the holder, trade dates, share counts, and gross amounts consistent with resale reporting rather than an issuer registration.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR